IMMATICS BIOTECHNOLOGIES GMBH
IMTXW -0.31
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
| Name | Value |
|---|
| Revenues | 50.6M |
| Cost of Revenue | 38.9M |
| Gross Profit | 50.6M |
| Operating Expense | 50.0M |
| Operating I/L | 0.5M |
| Other Income/Expense | -2.9M |
| Interest Income | 5.5M |
| Pretax | -2.4M |
| Income Tax Expense | 6.2M |
| Net Income/Loss | -8.6M |
immatics biotechnologies GmbH
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.
